tiprankstipranks
China SXT Pharmaceuticals Inc (SXTC)
NASDAQ:SXTC
Holding SXTC?
Track your performance easily

China SXT Pharmaceuticals (SXTC) Financial Statements

219 Followers

China SXT Pharmaceuticals Financial Overview

China SXT Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $2.2; its P/E ratio is 0.22; China SXT Pharmaceuticals is scheduled to report earnings on February 1, 2021, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Sep 22Mar 22Sep 21
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 12.07M$ 17.37M$ 2.98M$ 15.57M$ 31.32K
Total Assets$ 23.13M$ 29.55M$ 22.18M$ 33.55M$ 22.67M
Total Debt$ 2.65M$ 599.23K$ 1.21M$ 11.40K$ 24.04K
Net Debt$ -9.42M$ -16.77M$ -1.77M$ -15.56M$ -7.28K
Total Liabilities$ 9.20M$ 14.86M$ 7.29M$ 17.12M$ 8.88M
Stockholders Equity$ 13.93M$ 14.69M$ 14.89M$ 16.42M$ 13.79M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

China SXT Pharmaceuticals Earnings and Revenue History

China SXT Pharmaceuticals Debt to Assets

China SXT Pharmaceuticals Cash Flow

China SXT Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis